Results 1 to 10 of about 2,694 (50)

Massive Idiopathic Chronic Pericardial Effusion: A Case Report [PDF]

open access: yesJournal of Cardio-Thoracic Medicine, 2023
An idiopathic chronic pericardial effusion which has occurred due to pericardial fluid collection can continue for over a three-month duration without obvious cause. Massive chronic pericardial effusion without cardiac tamponade is quite unusual.
Mahdi Kahrom, Masoomeh Tabari
doaj   +1 more source

Tegafur‐uracil‐induced pericardial effusion during adjuvant chemotherapy for resected lung adenocarcinoma: A case report

open access: yesThoracic Cancer, 2021
In Japan, oral administration of tegafur‐uracil is recommended as postoperative adjuvant chemotherapy for patients diagnosed with primary lung adenocarcinomas of >2 cm size and staged as IA, IB, and IIA.
Nobutaka Kawamoto   +4 more
doaj   +1 more source

Pericardial effusion in idiopathic inflammatory myopathies: A cross-sectional study from Asia and review of the literature

open access: yesInternational Journal of Immunopathology and Pharmacology, 2022
Objectives Pericardial effusion is a rare clinical manifestation in idiopathic inflammatory myopathies (IIMs). It has been described in a small number of literature studies worldwide.
Yue Wang   +9 more
doaj   +1 more source

Pericardial effusion after congenital heart surgeryCentral MessagePerspective

open access: yesJTCVS Open, 2022
Objective: Pericardial effusion after cardiac surgery remains an important cause of morbidity and mortality. We describe the risk factors of pericardial effusion after congenital heart surgery through analyzing data from a nationwide, multi-institutional
Mio Noma, MD   +7 more
doaj   +1 more source

Pericardial effusion after definitive concurrent chemotherapy and intensity modulated radiotherapy for esophageal cancer

open access: yesRadiation Oncology, 2020
Background The literature regarding pericardial effusion after definitive concurrent chemotherapy and intensity modulated radiotherapy (IMRT) for esophageal cancer was lacking.
Tzu-Hui Pao   +6 more
doaj   +1 more source

Characteristics of Genomic Alterations in Pericardial Effusion of Advanced Non-small Cell Lung Cancer

open access: yesFrontiers in Genetics, 2022
Background: The feasibility and value of pericardial effusion as a liquid biopsy sample for actionable alteration detection in patients with non-small cell lung cancer (NSCLC) has not been adequately investigated.
Jiaxue He   +4 more
doaj   +1 more source

Unveiling the causes of pericardial effusion in a contemporary case series of pericardiocentesis in Latin America

open access: yesScientific Reports, 2022
Pericardial effusions requiring pericardiocentesis have multiple causes that vary among geographical regions and health contexts. This procedure can be performed for diagnostic or therapeutic indications.
Juan Hernando del Portillo-Navarrete   +6 more
doaj   +1 more source

A case of tuberculous pericardial effusion confirmed by GeneXpert MTB/RIF combined with literature review [PDF]

open access: yesZhenduanxue lilun yu shijian, 2023
This paper reported a case of tuberculous pericardial effusion which was confirmed by GeneXpert MTB/RIF (Mycobacterium tuberculosis rpoB gene and mutation detection).
PENG Rong, LI Mu, MA Kuo, GONG Qian
doaj   +1 more source

Reduction of pericardial effusion in advanced non-small cell lung cancer patients with KRAS, TP53, and MET mutation treated with nivolumab

open access: yesJournal of International Medical Research, 2020
Nivolumab is an immune checkpoint inhibitor that is used to treat various advanced cancers, including metastatic non-small cell lung cancer (NSCLC). Nivolumab treatment has different side effects.
Zhihui Cai, Yuan Yao
doaj   +1 more source

Continuous drainage for the treatment of gastric cancer with pericardial metastasis and cardiac tamponade: A case report

open access: yesClinical Case Reports, 2023
Key Clinical Message Signet‐ring cell gastric carcinomas presenting as pericardial effusion early in diagnosis are rare and associated with high mortality and a poor prognosis.
Tadayuki Hirai   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy